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The number of cancer patients using complementary and alternative medicine (CAM) in the United 
States is growing, yet little is known about the meaning these activities have for users. Current 
literature supports the assumption that stigma surrounding CAM and holistic health practices are 
responsible for the reluctance of many cancer patients to self-identify as CAM users. This study 
explored the frequency of use, and familiarity with CAM among 26 female patients at a Midwestern 
oncology clinic. Findings suggest that patients need to be asked about CAM use multiple times and in 
multiple formats to gain an accurate assessment. Also, the assumptions about stigma may no longer 
be the reason patients are less than forthcoming about CAM use. The rise of integrative medicine and 
shifting boundaries of the holistic health movement may be equally, or in some cases, more 
responsible for the reluctance for CAM users to self-identify. 
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The Unsuspecting CAM User:  
 
Cancer patients and the changing nature of holistic health   
 
 
A. M. Kabel & L.P. Johnson 
I. Introduction  
The estimated number of people who have been diagnosed with cancer in the United States has been on a 
steady increase for the past decade.  It is estimated that the number will grow beyond 13 million in the next decade 
(Eheman et al., 2012 and Alekruse et al., 2010). In 2011, Parry and colleagues published a seminal article calling for 
greater research on cancer survivorship and its conditions, especially as the population of survivors age.  In 
recognition to the growth of this population, in 2012, the American Cancer Society released its “Facts & Figures” 
report devoted entirely to the cancer survivor population (ACS, 2012).   
Continued advances in cancer detection and treatment strategies have increased the numbers of individuals 
living years beyond diagnoses (for some cancers), in some cases beyond 5 years (Aziz et al., 2003; ACS, 2003). 
Living with cancer often means coping with increased stress, poor health-related quality of life and unfulfilled 
psychosocial needs (Monti et al., 2005, National Research Council, 2008). Complementary and alternative medicine, 
or CAM therapies, have become increasingly popular among cancer patients and survivors, as a way to address the 
various shortcomings of conventional biomedical treatment.  According to an analysis done by Mao and colleagues, 
cancer survivors were more likely than the non-cancer control population to cite that they were using CAM because 
“medical treatments did not help” (Mao et al, 2011: 14, figure 2).  The areas where biomedicine is failing are far 
reaching.  In Mao’s study, the common uses for CAM among cancer survivors are:  
For wellness or general disease prevention; to enhance energy; to enhance immune function; to 
treat pain-related symptoms (including joint pain/aching, neck pain, back pain, other 
musculoskeletal, regular headaches, severe headaches/migraines); to treat psychological distress 
(including stress, anxiety, or depression), and to treat insomnia (Mao et al, 2011: 10).  
In a recent report assessing the care of cancer survivors and promoting better rehabilitation efforts on their 
behalf, Alfano and others (2012) stated the following: 
Depending on the specific treatment exposures, survivors of cancer can face numerous adverse 
consequences of cancer treatment, many of which are amenable to rehabilitation interventions. 
These include fatigue, depression, anxiety, fear of recurrence, cognitive dysfunction, pain 
syndromes, peripheral neuropathy, sexual dysfunction, balance and gait problems, upper or lower 
quadrant mobility issues, lymphedema, bladder and bowel problems, stoma care, problems with 
swallowing or dysphagia, and communication difficulty (2012: 905). 
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CAM therapies are defined as interventions neither widely taught nor generally available in U.S. hospitals 
(Eisenberg et al., 1993). The holistic approach of CAM is thought to be among its attractive features, for example, 
“Patient-centered care and patient empowerment are primary components of these [CAM] fields, as is the 
commitment to address the mind, body, and spiritual aspects of health” (Maizes, Rakel & Niemiec 2009: 278). Total 
CAM expenditures in the U.S. are in the billions of dollars, the majority of which are out-of-pocket costs (Eisenberg 
et al., 1993). The majority of CAM-using cancer patients and survivors combine them with conventional therapies 
(Boon et al., 2000; Richardson et al., 2000). In a study of CAM use by breast cancer and gynecological cancer 
patients in Texas, Navo et al, stated the reasons for using CAM among their study population was diverse:  
 
A higher proportion of patients in the MBC [Multidisciplinary Breast Center] stated their reasons for CAM use to be to 
improve quality of life and to decrease the adverse effects of other medications that they may be using. Also, 15% of 
patients in the GOC [Gynecological Oncology Center] stated that their reason for use was to treat their cancer. We 
found a wide variety of CAM in various formulations and doses being used for multiple indications. Identifying the 
most frequently used CAM was just one approach to prioritize the agents to evaluate first in the laboratory for drug 
interactions (2004: 676). 
 
Patient self-reporting to physicians of CAM use varies by cancer site, gender and other factors; from little 
to no reporting to as many as half of cancer patients reporting (Mao et al, 2011 and Yates et al 2005). Breast and 
ovarian cancer survivors are reported to be the most likely to use CAM (Gansler et al, 2008). According to a 2000 
report from the White House Commission on Complementary and Alternative Medicine Policy, the use of CAM is 
growing among Americans in general however, most people use it “in conjunction with, rather than as a replacement 
for, conventional medical therapy” (White House Commission 2000).  CAM modalities are as diverse as the patients 
using them.  In the study of patients undergoing cancer treatment by Yates et al., some of the modalities inquired 
about were: “exercise, prayer, relaxation, chiropractic, massage, imagery, spiritual healing, diets, herbal medicine, 
mega-vitamins, Self-help groups, hypnosis, and acupuncture” (2005:808). 
Patients are using CAM to treat well-known, but not always well-managed side effects of active treatment, 
and survivors are using CAM to treat lingering effects of the completed treatments and the more poorly understood 
late effects of cancer and its treatments.  Treatments for side effects and late effects are intended to help patients 
adjust to their ‘new normal’, however, patients are increasingly expressing their dissatisfaction with the 
effectiveness of these treatments alone, and frustration with the lack of appreciation for gaps that exist in some areas 
such as mental health, fertility, and legal/financial issues (Ehrenreich, 2001, Sulik 2011, King, 2008, Blank, 2009).  
Driving much of the survivor activism is younger survivor advocates in organizations such as the LiveStrong, Stupid 
Cancer and Young Survival Coalition.  However, the 2012 publication of the ACS cancer survivor document and the 
1996 creation of the National Cancer Institute’s Office of Survivorship show that interest in cancer survivor issues is 
becoming more mainstream. 
In 2005, the Institute of Medicine produced a comprehensive report called “From Cancer Patient to Cancer 
Survivor: Lost in Translation” intended to raise awareness of medical professionals’ lack of understanding of and 
communication about cancer survivors’ legal, medical, social, economic and psychological problems.  Some of the 
report’s recommendations (ie, the “Survivorship Care Plan”) have been implemented by cancer centers, but 
evidence-based treatments for long term effects for cancer are less widely known by providers. As physicians 
increasingly accept cancer survivorship as a distinct phase of cancer, the body of research aimed at understanding 
the long term physical and mental impacts of cancer treatment will continue to grow.  According to the ACS report 
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Long-term and late effects may be emotional (e.g., anxiety, depression) and/or physical (e.g., heart, 
lung and kidney damage, mental impairment, and infertility). Cancer survivors are also at risk for 
recurrence of the original cancer or the development of a new, biologically distinct, second primary 
cancer, with risk dependent on the original type of cancer, stage of disease, and treatments received 
(2012: 24)   
Cancer treatments vary and their long term impacts can vary by treatment (Alfano et al, 2012; Parry et al., 
2011; Fossa et al, 2007; Bennett et al, 2010). According to Zucca et al (2012) very few survivors have pain or other 
issues, suggesting an additional facet to the survivorship experience. Increasingly, we understand that the 
survivorship outcomes also are impacted by race, class, and younger age at treatment (ACS 2012).   
Weaver and others (2010) investigated the prevalence of cancer survivors doing without health care 
because of costs concerns.  This research outlined the following: 7.8% forgo medical care, and 9.9% forgo 
prescription medications, which is “greater than that reported for the US population in general, (5.2% and 7.2%, 
respectively) for the year 2005” (Weaver et al., 2010: 3501).  Also in this study, preliminary evidence confirms that 
race, type of cancer, and years since diagnosis impact a survivor’s decision to forgo health care because of cost 
concerns.  This information appears counter-intuitive to the well-documented and extensive use of CAM among 
people with chronic conditions including cancer (Monti, et al., 2002) and implies that compliance and adherence 
issues do not parallel CAM participation among American cancer patients/survivors.  
The widespread knowledge about CAM-using patient reluctance to self-identify has often been attributed to 
the stigma surrounding holistic approaches to health (Fennel et al., 2009; Rose 2009; Sewitch et al., 2008; Lewith 
2008; Rojas-Cooley and Grant 2009; Rhode et al., 2008).  This explanation is complicated by recent studies that 
suggest the under reporting of CAM use is due to a wide variety of factors, including patients not considering CAM 
a type of ‘real’ medicine (Navo et al., 2004).   In a study by Zhang et al., of family medicine patients, there were 
significant numbers of providers who did not feel that they understood or could adequately explain a variety of 
CAM modalities, and a literature review by Sewitch et al., (2008) found that confusion about, and negative attitudes 
toward CAM modalities was common across a number of studies for physicians (but not necessarily for other staff).  
This literature review also indicated that physicians are increasingly interested in learning about and understanding 
CAM modalities. The recent growth of CAM use and popularity of integrative medicine provide an opportunity to 
reexamine the stigma assumption. This study examined the familiarity with, frequency of, and willingness to admit 
CAM use among female cancer patients at a Midwestern oncology clinic. The specific types of CAM therapies used 
were explored to gain insight into the motivations for use. 
II. Methods 
This survey was designed to determine if cancer patients used CAM therapies and, if so, which therapies. A 
descriptive survey design was developed and data was collected through a questionnaire. We hypothesized that 
patients tend to under-report CAM utilization, requiring redundancy (asking same question multiple ways) in the 
survey design. This embedded redundancy was intended to more accurately capture participant experience with 
CAM therapies. IRB permission was secured before any recruitment or data collection took place.  
A convenience sample of 26 newly diagnosed or relapsed female cancer patients were recruited at a 
women’s cancer clinic in the Midwest.  Recruitment took place over approximately three weeks and participants 
were recruited in the waiting area of the clinic. The oncologist to whom these patients were referred (and where 
these data were collected) was female and had a reputation for being supportive of patients using CAM therapies.  
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Individuals interested in participating in this study were given more information, consented and surveyed in a 
private room. Volunteers were assured that input was voluntary, confidential and would have no impact upon their 
right to continue treatment at the clinic. One volunteer was recruited and later dropped out of the study due to lack 
of cancer diagnosis. All study participants were invited to share their history and experiences regarding the use of 
CAM therapies via the guided questionnaire. Patients needed to be at least 18 years and older with no language 
barrier or inability to read.  Results were entered into a spread sheet and tabulated. 
Participants 
The participants (n=25) were all female cancer patients (See table 1 for type and frequency of cancers). 
Their ages ranged from 38 to 91 years, with a mean age of 57.84 and median of 57.0. 23 self-identified as white, non 
Hispanic, and 2 as Hispanic women.   
Findings 
Our findings supported existing literature regarding the prevalence 
of CAM use among the patient population and confirmed patient 
reluctance to admit using CAM therapies. Twelve (48%) of the 
participants answered “no” when asked if they used CAM, but 
upon further questioning, described using one or more of these 
therapies. For the participants as a whole (n=25), the therapies 
they used included: acupuncture (4), meditation (6), supplements 
(21), prayer (9), chiropractic (2), massage (12), yoga (8), aroma 
therapy (5), organic diet (2), and reflexology (3). Participants 
reported using the following medicinal plants: chamomile tea, aloe 
vera, Echinacea, elderberry, green tea, rosemary, St. John’s Wart, 
garlic, ginger, milk thistle, lavender, evening primrose oil.  
Patients used CAM alongside traditional therapies and only 2 received information about CAM from health care 
providers. The rest reported using various media or other sources for information about CAM. None of the 
participants reported using traditional Chinese medicine or Ayurvedic therapies. Among the patients self-identifying 
as non-CAM users, they reported using aloe and aloe vera, chamomile, cranberry, Echinacea, evening primrose oil, 
green tea and garlic, among other supplements.  
Of the ten participants diagnosed with ovarian cancer, nine, or 90% reported using CAM therapies. Specifically, 
they reported using herbal supplements (9), following a special/macrobiotic diet (2), receiving acupuncture (3), 
meditating (4), praying for health (3), receiving massage therapy (2), practicing yoga (5), reflexology (2), reiki (1), 
aroma therapy (1) and using a natural healer (3).  
III. Discussion  
About half of our participants denied CAM use when first asked, but revealed participation in several CAM 
therapies after being asked multiple times.  The majority of participants did not discuss the use of these therapies 
with their physicians and physicians did not typically ask patients about CAM. This mirrors what has been 
documented in current literature on provider-patient discussions about CAM (Eisenberg, 1997; Boon et al., 2000; 
Richardson et al., 2000, Sewitch et al., 2008).  This pattern can be interpreted as indicating either a health literacy 
Diagnosis Frequency 















Health, Culture and Society  
Volume 6, No. 1 (2014)  |  ISSN 2161-6590 (online)  |  DOI 10.5195/hcs.2014.85  |  http://hcs.pitt.edu 
102 
 
barrier, (lack of understanding about these activities [Fennell, 2009]) or a concern about being exposed as a CAM 
user (stigma), and being judged negatively by the provider (Rojas-Cooley and Grant 2009;  Rhode 2008; Sewitch et 
al., 2008). One possible explanation for this is that the CAM-using patients who do not self-define are looking for 
the more passive types of CAM.  
Passive CAM use includes supplements and activities that do not require a significant amount of effort, 
research or lifestyle change, such as taking a pill or receiving a treatment. CAM use is typically thought about in 
terms of an active health-related decision making however, and not associated with passive behavior.  Navo et al., 
(2004) would agree; their interpretations suggest that CAM use represents patient empowerment and is not 
mentioned at doctor visits because it is not necessarily considered medicine by its users: 
Of the patients defined as CAM users, most gathered information about CAM on their own by 
using resources such as the internet or the media. CAM users also seemed to look to their social 
support like friends and family for their opinion. Not surprisingly, healthcare professionals were 
third in line when listed as a likely resource for patients. This information demonstrates that 
patients are making an effort to take an active role in their own healthcare. Also, less than a third of 
all patients considered CAM a type of medication, which may contribute to the low incidence of 
reporting of CAM use to healthcare professionals when giving a medication history. The majority 
of patients who spoke to any healthcare professional felt positive about their conversation. Of those 
who had not discussed CAM with a professional, the most common reason was that it was never 
brought up during their visit (Navo et al., 2004: 676). 
Participants were not uniform in their attitude toward or use of CAM.  Participants diagnosed with ovarian 
cancer represented the largest diagnostic group in our study. 90% of the ovarian cancer patients in our study reported 
using some form of CAM. The literature suggests breast and ovarian cancer patients are the most likely to use CAM, 
and survivors of distant, or more advanced disease are more likely to use CAM than patients with local disease 
(Gansler et al., 2008).  This is perhaps due to the fact that ovarian cancer is infrequently diagnosed in its early 
stages, resulting in newly diagnosed patients who are further along the illness trajectory, the greater uncertainty of 
treatment outcomes with ovarian cancer specifically, and cancers detected at later phases in general.  These patients 
were as a group, the least reluctant to self-identify as CAM users among the participants in this study. 
The reluctance of CAM users to self identify reflects the shifting boundaries of the holistic health 
movement’s transition toward integrative medicine.  Herbal supplements and alternative therapies were once (and 
not long ago) considered marginal among clinicians, however many of these practices have been absorbed into 
biomedicine and are mainstream care options (Rose et al, 2009; Lewith et al., 2008; Giordano et al 2002). Herbal 
supplements once found only in specialty shops are now mass produced and widely available. Our participants 
purchased and consumed products recommended to them by friends, or health professionals, perhaps without 
realizing that these products were associated with alternative or holistic health.  
Participants used CAM alongside conventional treatment, and for the for the most part did not see the use 
of these therapies as a challenge to biomedicine. In these instances, CAM became shorthand for complementary 
methods used in conjunction with traditional biomedicine or allopathic medicine and may have been incorporated 
into their “pathways of survivorship” (Blank 2009: 425). Patients did not feel the need to inform, consult or seek 
permission from the oncologist about their CAM use, reflecting the changing expectations for provider-patient 
communication. CAM use was not an issue that threatened their status as ‘good’ cancer patients because they were 
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seeking out supplements and therapies they believed would support their overall well being.  
IV.   Conclusion  
With advances in cancer prevention education, early screening awareness and treatments for cancer, the 
number of cancer people being treated for, and surviving cancer, has grown dramatically since President Nixon’s 
declaration on the war against cancer in 1971 (marked by the signing of the National Cancer Act).  Although five-
year survival rates vary by cancer types, stages, ages, race and class, many of those diagnosed with cancer today can 
expect to live long and full lives.  These lives, however, are not free of challenges.  It is increasingly understood that 
many (but not all) cancer patients/survivors deal with a myriad of emotional, financial, physical, legal and mental 
burdens that result from their cancer diagnoses.  So, as the technologies for cancer detection and treatment have 
expanded since Nixon’s declaration, the science surrounding the long term and late effects of cancer treatment is, 
unfortunately, lagging.  The call to alleviate this delay in scientific and clinical understanding of survivorship has 
grown louder, and, as signaled by the 2012 American Cancer Society report about the growing survivor population, 
is being heard by those in the oncology community.   
In roughly the same time period that we have seen this exponential growth in cancer outcomes, we have 
seen a slower, but equally steady, use by the general American population of treatments called CAM, or 
complementary and alternative medicine.  This movement to use CAM therapies was fueled by the patient 
empowerment movements that began in the 1970s.  The range of treatments called CAM, is wide in application and 
availability, however, more Americans are admitting to its use.  CAM use is not necessarily a seen as a subversion 
of mainstream medicine—studies of CAM users frequently point to the fact that CAM is often seen as a supplement, 
rather than replacement for, traditional Western biomedicine.  The reasons for using CAM vary by patients and, 
even by illness, but CAM users often seek to “fill in the gaps” where traditional medicine has missed, or not 
completely addressed, a medical issue or symptom.  As with the larger population, cancer patients/survivors seek to 
use CAM for these same reasons.  The cancer experience can be disruptive for some, and the late and long term 
cancer effects can impact several domains of the lives of patients/survivors and, therefore, it makes sense that some 
gravitate to these more self-empowering and holistic approaches in their journey to their ‘new normal’.  In many 
studies, breast cancer and gynecological cancer patients seem to be the most willing cancer patients to admit to 
CAM use. 
However popular these modalities have become, the patient-provider communication about the use of 
CAM remains difficult or non-existent.  Studies about average Americans and cancer patients/survivors consistently 
show that care providers do not routinely ask about and understand CAM use and patients do not regularly initiate a 
conversation about CAM.  These studies about CAM use among various patient populations point to a multitude of 
reasons—poor provider understanding, provider bias, health literacy, poor health communication, patient 
embarrassment, and patients not understanding that CAM is in fact medicine.  Of the 25 women we surveyed, only 
two reported receiving information about CAM from a health care provider.  
It is in this context that we undertook a study aimed at understanding the prevalence of use of CAM 
modalities among female cancer patients/survivors in a Midwestern cancer specialty practice.  This was a practice 
headed by a female physician known to be open to discussion about cancer patients’ use of CAM.  The study 
involved a voluntary survey of patients from this clinic.  The survey was administered in person to 26 patients (with 
one dropping out).  With the heightened visibility of CAM methods in the larger American culture (and, therefore, 
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repetition and detail in order for the researchers to be assured that they had a clear picture of CAM use among this 
population.  Among the population studied, CAM use was common and included a number of different kinds (with 
no use of Chinese or Ayruvedic medicine).  Analysis of the survey data revealed that people who initially did not 
classify themselves as CAM users were in fact, using products and services that fall under the CAM categories.  
These were “unsuspecting” CAM users. 
Upon closer inspection, a majority (90%) of ovarian cancer patients/survivors in the study were enthusiastic 
supporters of CAM, using an extensive menu of modalities, many at the same time.  This finding is perhaps 
unsurprising—as SEER data points to more frequent late diagnoses of ovarian cancer patients.   In popular media, 
ovarian cancer is sometimes referred to the “silent killer” because its symptoms are often mistaken for other 
conditions, such as stomach pain, fullness, gas/bloating, that are treated with OTC therapies. These ovarian cancer 
patients had an attitude that stands in contrast to the other participants in this study.  
Implications 
It is imperative that health professionals find multiple ways to inquire about the use of CAM therapies with 
their cancer patients. Direct questioning is not likely to yield accurate results for several reasons. Patients are not 
necessarily afraid to tell physician/provider about CAMs, although that is possible. Patients likely do not think of the 
mass produced, widely available products and therapies they use as CAM, or as actual medicine. Patients are curious 
about natural healing products and the realities of living with cancer and cancer survivorship can leave them feeling 
unwell or vulnerable to further health problems. This vulnerability may cause CAM therapies to appear more 
attractive to cancer patients and survivors. It is possible that cancer patients in general and specifically ovarian 
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